Bristol-Myers Squibb
BMY
61.27
-0.98
-1.57%
Bristol-Myers Squibb
US · BMY
#122 by market cap
Listed 1970
-1.57%
61.27
-0.98
-1.57%
Live - 304 symbols - heartbeat 507s ago
· 2026-09-23 15:50
Pre-market
62.12
-0.21%
After-hours
62.30
+0.08%
Overnight
62.45
+0.32%
- Market cap
- 125.16B
- P/E (TTM)i
- 13.50
- P/Bi
- 5.61
- EPSi
- 3.46
- Div yieldi
- 4.10%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on BMY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 11 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 83.23% -0.20pp
- Institutions
- 2,901 -11
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund68.65%
Public Company3.88%
Hedge Fund2.87%
Government Pension Fund2.62%
Private Company2.14%
Sovereign Wealth Fund1.90%
Insurance Company0.36%
Family Office/Trust0.32%
VC/PE Fund0.17%
Other17.09%
Top holders
| Holder | Stake |
|---|---|
| BlackRock | 8.83% |
| Vanguard Capital Management, LLC | 7.09% |
| State Street Global Advisors | 5.01% |
| Charles Schwab Investment Management | 3.31% |
| J.P. Morgan Asset Management, Inc. | 2.89% |
| Other | 72.86% |
Insiders
26 filings tracked · 6 buys · 7 sells
| Name | Role | Stake |
|---|---|---|
| Sandra Leung | Executive Vice President | 0.02% |
| David Elkins | Chief Financial Officer | 0.01% |
| Christopher Boerner | Chief Operating Officer | 0.01% |
| Theodore Samuels | Lead Independent Director | 0.00% |
| Julia Haller | Independent Director | 0.00% |
| Samit Hirawat | Executive VP & Chief Medical Officer of Drug Development | 0.00% |
| Greg Meyers | Executive VP and Chief Digital & Technology Officer | 0.00% |
| Adam Lenkowsky | Executive VP, Chief Commercialization Officer & Head of U.S. Oncology | 0.00% |
| Karin Shanahan | Executive Vice President of Global Product Development & Supply | 0.00% |
| Robert Plenge | Executive VP, Chief Research Officer & Head of Research | 0.00% |
Quote time 2026-09-23 15:50:03 · For reference only, not investment advice.